Therna Biosciences
Latest round
- Seed
Last raised
- Aug 2025
Total raised
- $9.2M
Investors
- 3
About Therna Biosciences
Based in California, US, and founded in 2023, Therna Biosciences specializes in programmable RNA therapeutics. Co-founded by Nazli Azimi (CEO), Hani Goodarzi, and Sasan Amini. Therna specializes in the development of programmable RNA therapeutics through its proprietary generative RNA design platform. This innovative platform integrates deep RNA biology with generative artificial intelligence, allowing for the creation of custom mRNA sequences that can express, silence, or fine-tune gene activity. The main applications of these products include therapeutic interventions for diseases that traditional drug modalities have struggled to address, providing targeted solutions in areas like oncology, genetic disorders, and infectious diseases. The company's technology enables researchers and pharmaceutical companies to quickly and precisely design RNA-based medicines tailored to specific therapeutic needs, primarily utilized in North America and Europe. Therna has established a revenue model centered on partnerships with pharmaceutical companies and research institutions, focusing on B2B transactions that leverage their unique RNA design capabilities. These engagements typically involve collaborations or licensing agreements allowing clients to access Therna's platform for developing custom RNA therapeutics. Additionally, subscription-based arrangements may provide ongoing access to their technology, creating a continuous revenue stream from both large pharmaceutical enterprises and smaller biotech firms, with pricing based on the scope and complexity of services utilized.
Who invested in Therna Biosciences
3 investors across 1 round
See all investors in Therna Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 26, 2025
Amount
$9.2M
Investors
Questions about Therna Biosciences
Who invested in Therna Biosciences?
Therna Biosciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Therna Biosciences raised?
Therna Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Therna Biosciences last raise money?
Therna Biosciences's most recent round on record is a Seed, in Aug 2025.
What does Therna Biosciences do?
Based in California, US, and founded in 2023, Therna Biosciences specializes in programmable RNA therapeutics.
Where is Therna Biosciences headquartered?
Therna Biosciences is headquartered in San Francisco, US.
Which VCs invest in companies like Therna Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Therna Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Therna Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.